Cerora clinical study presented at NJ Tech Council’s Mid-Atlantic Brain Research Conference

From Startup Cerora

Link to Full Article:

Cerora clinical study presented at NJ Tech Council’s Mid-Atlantic Brain Research Conference

North Brunswick, NJ, Rutgers Commercialization Center for Innovative Technology, April 17, 2018 – Dr. David M. Devilbiss, now Associate Professor, Cell Biology and Neuroscience, Rowan University, presented “Classification of concussion with combined cognitive and electrophysiological measures” on preliminary analysis results from his work while Chief Technology Officer at Cerora. Dr. Devilbiss addressed the question can sideline assessment tools be improved by combining neuropsychological tests and qEEG signatures? The brief presentation gave an overview of the Cerora study results from the Tahoe Study (conducted in collaboration with the Tahoe Institute for Rural Health Research, TIRHR) as well as the much more extensive Lehigh Study (conducted in collaboration with Lehigh University Sports Medicine). A multivariate logistic model was shown that combined both symptoms and two qEEG features.

Please visit their site for more information: Cerora.com

All,Digital,Healthcare News,Medical Device
2018-06-22 04:10:36